Низкомолекулярные пептидные препараты, полученные из культивированных стволовых клеток, при лечении острой почечной недостаточности

Data on the efficiency of low-molecular peptide preparations, selected from cultivated stem cells of marrow, in the treatment of acute kidney insufficiency in experimental animals are resulted. It is demonstrated that the use of peptide preparations reliably promotes survivability of experimental animals suffering from acute kidney insufficiency.